These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

765 related articles for article (PubMed ID: 25175867)

  • 1. Interactions of HIV and drugs of abuse: the importance of glia, neural progenitors, and host genetic factors.
    Hauser KF; Knapp PE
    Int Rev Neurobiol; 2014; 118():231-313. PubMed ID: 25175867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opiate drug use and the pathophysiology of neuroAIDS.
    Hauser KF; Fitting S; Dever SM; Podhaizer EM; Knapp PE
    Curr HIV Res; 2012 Jul; 10(5):435-52. PubMed ID: 22591368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 neuropathogenesis: glial mechanisms revealed through substance abuse.
    Hauser KF; El-Hage N; Stiene-Martin A; Maragos WF; Nath A; Persidsky Y; Volsky DJ; Knapp PE
    J Neurochem; 2007 Feb; 100(3):567-86. PubMed ID: 17173547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 alters neural and glial progenitor cell dynamics in the central nervous system: coordinated response to opiates during maturation.
    Hahn YK; Podhaizer EM; Hauser KF; Knapp PE
    Glia; 2012 Dec; 60(12):1871-87. PubMed ID: 22865725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphine potentiates neurodegenerative effects of HIV-1 Tat through actions at μ-opioid receptor-expressing glia.
    Zou S; Fitting S; Hahn YK; Welch SP; El-Hage N; Hauser KF; Knapp PE
    Brain; 2011 Dec; 134(Pt 12):3616-31. PubMed ID: 22102648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A central role for glial CCR5 in directing the neuropathological interactions of HIV-1 Tat and opiates.
    Kim S; Hahn YK; Podhaizer EM; McLane VD; Zou S; Hauser KF; Knapp PE
    J Neuroinflammation; 2018 Oct; 15(1):285. PubMed ID: 30305110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NeuroHIV and use of addictive substances.
    Chang SL; Connaghan KP; Wei Y; Li MD
    Int Rev Neurobiol; 2014; 118():403-40. PubMed ID: 25175871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glial mechanisms underlying substance use disorders.
    Linker KE; Cross SJ; Leslie FM
    Eur J Neurosci; 2019 Aug; 50(3):2574-2589. PubMed ID: 30240518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. beta-Chemokine production by neural and glial progenitor cells is enhanced by HIV-1 Tat: effects on microglial migration.
    Hahn YK; Vo P; Fitting S; Block ML; Hauser KF; Knapp PE
    J Neurochem; 2010 Jul; 114(1):97-109. PubMed ID: 20403075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 and morphine regulation of autophagy in microglia: limited interactions in the context of HIV-1 infection and opioid abuse.
    El-Hage N; Rodriguez M; Dever SM; Masvekar RR; Gewirtz DA; Shacka JJ
    J Virol; 2015 Jan; 89(2):1024-35. PubMed ID: 25355898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glial modulators as potential treatments of psychostimulant abuse.
    Beardsley PM; Hauser KF
    Adv Pharmacol; 2014; 69():1-69. PubMed ID: 24484974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of substance abuse on HIV-mediated neuropathogenesis in the current ART era.
    Chilunda V; Calderon TM; Martinez-Aguado P; Berman JW
    Brain Res; 2019 Dec; 1724():146426. PubMed ID: 31473221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neural stem cells and neuro/gliogenesis in the central nervous system: understanding the structural and functional plasticity of the developing, mature, and diseased brain.
    Yamaguchi M; Seki T; Imayoshi I; Tamamaki N; Hayashi Y; Tatebayashi Y; Hitoshi S
    J Physiol Sci; 2016 May; 66(3):197-206. PubMed ID: 26578509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glial and neuroinflammatory targets for treating substance use disorders.
    Bachtell RK; Jones JD; Heinzerling KG; Beardsley PM; Comer SD
    Drug Alcohol Depend; 2017 Nov; 180():156-170. PubMed ID: 28892721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphine and gp120 toxic interactions in striatal neurons are dependent on HIV-1 strain.
    Podhaizer EM; Zou S; Fitting S; Samano KL; El-Hage N; Knapp PE; Hauser KF
    J Neuroimmune Pharmacol; 2012 Dec; 7(4):877-91. PubMed ID: 22101471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human immunodeficiency virus-associated neurocognitive disorder: pathophysiology in relation to drug addiction.
    Nath A
    Ann N Y Acad Sci; 2010 Feb; 1187():122-8. PubMed ID: 20201849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of extracellular signal-regulated kinase (ERK1/2)-p53-p21 axis in mediating neural stem/progenitor cell cycle arrest in co-morbid HIV-drug abuse exposure.
    Malik S; Saha R; Seth P
    J Neuroimmune Pharmacol; 2014 Jun; 9(3):340-53. PubMed ID: 24469921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine Levels Induced by Substance Abuse Alter Efficacy of Maraviroc and Expression of CCR5 Conformations on Myeloid Cells: Implications for NeuroHIV.
    Matt SM; Nickoloff-Bybel EA; Rong Y; Runner K; Johnson H; O'Connor MH; Haddad EK; Gaskill PJ
    Front Immunol; 2021; 12():663061. PubMed ID: 34093554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of opiate-HIV-1 interactions on neurotoxic signaling.
    Hauser KF; El-Hage N; Buch S; Nath A; Tyor WR; Bruce-Keller AJ; Knapp PE
    J Neuroimmune Pharmacol; 2006 Mar; 1(1):98-105. PubMed ID: 18040795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional Regulator ZEB2 Is Essential for Bergmann Glia Development.
    He L; Yu K; Lu F; Wang J; Wu LN; Zhao C; Li Q; Zhou X; Liu H; Mu D; Xin M; Qiu M; Lu QR
    J Neurosci; 2018 Feb; 38(6):1575-1587. PubMed ID: 29326173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.